Here’s Why argenx SE (ARGX) Rose in Q3

3 days ago 2

Soumya Eswaran

Thu, November 13, 2025 astatine 6:58 AM CST 2 min read

ClearBridge Investments, an concern absorption company, released its “ClearBridge Mid Cap Strategy” third-quarter 2025 capitalist letter. A transcript of the missive tin beryllium downloaded here. In an situation of shifting monetary policy, stabilizing earnings, and improved sentiment, midcaps experienced maturation successful the 3rd quarter. The Federal Reserve’s determination to chopped rates helped tiny and mid-cap stocks successful the quarter. Value stocks outperformed their maturation counterparts with the Russell Midcap Value Index returning 6.2% compared to the Russell Midcap Growth’s 2.8% return. In this environment, the strategy outperformed its Russell Midcap Index during the 3rd quarter. Stock enactment successful the user staples and healthcare sectors drove outperformance of the strategy. In addition, delight cheque the fund’s apical 5 holdings to cognize its champion picks successful 2025.

In its third-quarter 2025 capitalist letter, ClearBridge Mid Cap Strategy highlighted stocks specified arsenic Argenx SE (NASDAQ:ARGX). Argenx SE (NASDAQ:ARGX) is simply a commercial-stage biopharma company. The one-month instrumentality of Argenx SE (NASDAQ:ARGX) was 9.11%, and its shares gained 48.48% of their worth implicit the past 52 weeks. On November 12, 2025, Argenx SE (NASDAQ:ARGX) banal closed astatine $889.89 per share, with a marketplace capitalization of $54.79 billion.

ClearBridge Mid Cap Strategy stated the pursuing regarding Argenx SE (NASDAQ:ARGX) successful its 3rd 4th 2025 capitalist letter:

"Health attraction was different cardinal operator of outperformance, anchored by spot successful biotechnology and the summation of caller opportunities successful beingness sciences tools. Argenx SE (NASDAQ:ARGX) delivered robust second-quarter results, supported by continued adoption of its pb therapy for autoimmune disorders and promising advancement crossed its objective pipeline."

Is argenx SE (ARGX) the Best Cancer Stock to Invest successful for Long-Term Gain?

Argenx SE (NASDAQ:ARGX) is not connected our database of 30 Most Popular Stocks Among Hedge Funds. According to our database, 53 hedge money portfolios held Argenx SE (NASDAQ:ARGX) astatine the extremity of the 2nd quarter, compared to 54 successful the erstwhile quarter. While we admit the imaginable of Argenx SE (NASDAQ:ARGX) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

In another article, we covered Argenx SE (NASDAQ:ARGX) and shared Baron Health Care Fund's views connected the company. In addition, delight cheque retired our hedge money capitalist letters Q3 2025 page for much capitalist letters from hedge funds and different starring investors.